Multivariate evaluation of the functional recovery obtained by the overexpression of utrophin in skeletal muscles of the mdx mouse

Neuromuscular Disorders

Volumn 12, Issue SUPPL., 2002, Pages

  Gillis, Jean Marie ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Dystrophin; mdx mouse; Skeletal muscle; Utrophin

Indexed keywords

DYSTROPHIN; UTROPHIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CONVALESCENCE; MOUSE; MOUSE STRAIN; MULTIVARIATE ANALYSIS; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SCORING SYSTEM; SKELETAL MUSCLE;

ANIMALS; CALCIUM; CYTOSKELETAL PROTEINS; DYSTROPHIN; GENE THERAPY; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MULTIVARIATE ANALYSIS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; RECOVERY OF FUNCTION; UP-REGULATION; UTROPHIN;

EID: 0036823983     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00088-3     Document Type: Conference Paper

References (25)

1. Tinsley J.M., Blake D.J., Roche A., et al. Primary structure of dystrophin-related protein. Nature. 360:1992;591-592.
2. Fardeau M., Tomé F.M.S., Collin H., et al. Présence d'une protéine de type dystrophine au niveau de la jonction neuromusculaire dans la dystrophie musculaire de Duchenne et la souris mutante 'mdx'. C R Acad Sci Paris. 311:1990;197-204.
3. Khurana T.S., Watkins S.C., Chafey P., et al. Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord. 1:1991;185-194.
4. Mizumo Y., Nonaka I., Hirai S., et al. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD carriers and control subjects. J Neurol Sci. 119:1993;43-52.
5. Tinsley J.M., Potter A.C., Phelps S.R., Fisher R., Trickett J.I., Davies K.E. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature. 384:1996;349-353.
6. Matsumura K., Campbell K.P. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve. 17:1994;2-15.
7. Winder S.J., Kendrick-Jones J. Calcium/calmodulin-dependent regulation of the NH2 terminal F-actin binding domain of utrophin. FEBS Lett. 357:1995;125-128.
8. Gillis J.M. Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse [In Process Citation]. J Muscle Res Cell Motil. 20:1999;605-625.
9. Carlson C.G., Makiejus R.V. A noninvasive procedure to detect muscle weakness in the mdx mouse. Muscle Nerve. 13:1990;480-484.
10. Weller B., Karpati G., Carpenter S. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci. 100:1990;9-13.
11. Moens P., Baatsen P.H.W.W., Maréchal G. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil. 14:1993;446-451.
12. Deconinck N., Ragot T., Maréchal G., et al. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc Natl Acad Sci USA. 93:1996;3570-3574.
13. Bodensteiner J.B., Engel A.G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibres in 114 biopsies. Neurology. 28:1978;439-446.
14. Gailly P., Boland B., Himpens B., et al. Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium. 14:1993;473-483.
15. Turner P.R., Fong P., Denetclaw W.F., et al. Increased calcium influx in dystrophic muscle. J Cell Biol. 115:1991;1701-1712.
16. Turner P.R., Westwood T., Regen C.M., et al. Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature. 355:1988;735-738.
17. 2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres. Pflügers Arch. 426:1994;499-505.
18. Collet C., Allard B., Tourneur Y., et al. Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice. J Physiol. 520:1999;417-429.
19. Tutdibi O., Brinkmeier H., Rudel R., et al. Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers. J Physiol. 515:1999;859-868.
20. Imbert N., Vandebrouck C., Constantin B., et al. Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro. Neuromuscul Disord. 6:1996;351-360.
21. 2+ indicators with greatly improved fluorescent properties. J Biol Chem. 260:1985;3440-3450.
22. Deconinck N., Tinsley J., De Backer F., et al. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat Med. 3:1997;1216-1221.
23. Tinsley J., Deconinck N., Fisher R., et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med. 4:1998;1441-1444.
24. Ahmad A., Brinson M., Hodges B.L., et al. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for Duchenne muscular dystrophy. Hum Mol Genet. 9:2000;2507-2515.
25. Deconinck A.E., Rafael J.A., Skinner J.A., et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 90:1997;717-727.